Nanosonics Limited (NAN) announces that it has commenced production and commercial sale of its breakthrough TrophonTM EPR ultrasound probe disinfector system, through distribution partners in New Zealand and Australia. Shipments, comprising Trophon EPR systems and NanoNebulantTM consumables, have been allocated to fulfil purchase orders already placed on the distribution partners by their customers, clinical end-users of the products.
The Company has undertaken a full sales launch to ultrasound professionals, including trade advertising and sales presentations to key opinion leaders and clinics throughout Australasia. Sales demand is being driven by the unique value proposition provided by the Trophon EPR system in the medical ultrasound market. A contributing factor to this demand is the greater awareness and vigilance of mandated legislation, regulatory requirements and the significant OH&S issues facing hospital and clinic staff.